Nunna Ravi S, Borghei Alireza, Brahimaj Bledi C, Lynn Fiona, Garibay-Pulido Diego, Byrne Richard W, Rossi Marvin A, Sani Sepehr
Department of Neurosurgery, Rush University Medical Center, Chicago, Illinois.
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois.
Neurosurgery. 2021 Jan 13;88(2):261-267. doi: 10.1093/neuros/nyaa381.
Responsive neuromodulation (RNS) is a treatment option for patients with medically refractory bilateral mesial temporal lobe epilepsy (MTLE). A paucity of data exists on the feasibility and clinical outcome of hippocampal-sparing bilateral RNS depth lead placements within the parahippocampal white matter or temporal stem.
To evaluate seizure reduction outcomes with at least a 1-yr follow-up in individuals with bilateral MTLE undergoing hippocampus-sparing implantation of RNS depth leads.
A retrospective analysis of prospectively collected data was performed on patients at our institution with bilateral MTLE who were implanted with RNS depth leads along the longitudinal extent of bitemporal parahippocampal white matter or temporal stem. Baseline and postoperative seizure frequency, previous surgical interventions, and postimplantation electrocorticography and stimulation data were analyzed.
Ten patients were included in the study (7 male, 3 female). Overall seizure frequency declined by a median 44.25% at 3.13 yr (standard deviation 3.31) postimplantation. Four patients (40%) achieved 50% responder rate at latest follow-up. Two of four patients with focal onset bilateral tonic-clonic seizures became completely seizure-free. Forty percent of patients were previously implanted with a vagus nerve stimulator, and 20% underwent a prior temporal lobectomy. All depth lead placements were confirmed as radiographically located in the parahippocampal white matter or temporal stem without hippocampus violation. There were no cases of lead malposition.
Extrahippocampal or temporal stem white matter targeting during RNS surgery for bitemporal MTLE is feasible and allows for electrographic seizure detection. Larger controlled studies with longer follow-up are needed to validate these preliminary findings.
响应性神经调节(RNS)是药物难治性双侧内侧颞叶癫痫(MTLE)患者的一种治疗选择。关于在海马旁白质或颞叶干内进行保留海马的双侧RNS深度电极植入的可行性和临床结果的数据较少。
评估接受保留海马的RNS深度电极植入的双侧MTLE患者至少1年随访后的癫痫发作减少情况。
对在我们机构接受双侧MTLE治疗并沿双侧颞叶海马旁白质或颞叶干的纵向范围植入RNS深度电极的患者进行前瞻性收集数据的回顾性分析。分析基线和术后癫痫发作频率、既往手术干预以及植入后皮质脑电图和刺激数据。
10名患者纳入研究(7名男性,3名女性)。植入后3.13年(标准差3.31)时,总体癫痫发作频率中位数下降44.25%。4名患者(40%)在最新随访时达到50%的反应率。4名局灶性发作双侧强直阵挛性癫痫患者中有2名完全无癫痫发作。40%的患者先前植入了迷走神经刺激器,20%的患者先前接受了颞叶切除术。所有深度电极植入经影像学证实位于海马旁白质或颞叶干,未侵犯海马。没有电极位置不当的情况。
在双侧MTLE的RNS手术中靶向海马外或颞叶干白质是可行的,并且能够进行脑电图癫痫检测。需要进行更大规模、随访时间更长的对照研究来验证这些初步发现。